Myosin 9 Antikörper (Middle Region)

Produktnummer ABIN631312

Produktdetails anti-Myosin 9 Antikörper

Target: Myosin 9 (MYH9)

Bindungsspezifität: Middle Region

Reaktivität: Human

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser Myosin 9 Antikörper ist unkonjugiert

Applikation: Western Blotting (WB)

Spezifität: MYH9 antibody was raised against the middle region of MYH9

Aufreinigung: Affinity purified

Immunogen: MYH9 antibody was raised using the middle region of MYH9 corresponding to a region with amino acids DAMNREVSSLKNKLRRGDLPFVVPRRMARKGAGDGSDEEVDGKADGAEAK

Anwendungsinformationen

Applikationshinweise: WB: 1 µg/mL
Optimal conditions should be determined by the investigator.

Kommentare:

MYH9 Blocking Peptide, catalog no. 33R-1860, is also available for use as a blocking control in assays to test for specificity of this MYH9 antibody

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Lyophilized

Rekonstitution: Lyophilized powder. Add distilled water for a 1 mg/mL concentration of MYH9 antibody in PBS

Konzentration: Lot specific

Buffer: PBS

Handhabung: Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use.

Lagerung: 4 °C/-20 °C

Informationen zur Lagerung: Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.

Details zu Myosin 9

Target: Myosin 9 (MYH9)

Andere Bezeichnung: MYH9 (MYH9 Produkte)

Synonyme: BDPLT6 antikoerper, DFNA17 antikoerper, EPSTS antikoerper, FTNS antikoerper, MHA antikoerper, NMHC-II-A antikoerper, NMMHC-IIA antikoerper, NMMHCA antikoerper, C80049 antikoerper, D0Jmb2 antikoerper, E030044M24Rik antikoerper, Fltn antikoerper, Myhn-1 antikoerper, Myhn1 antikoerper, NMHC II-A antikoerper, NMHCIIA antikoerper, NMMHC II-a antikoerper, NMMHC-A antikoerper, TU72.6 antikoerper, fi22c04 antikoerper, myh9 antikoerper, myh9l2 antikoerper, wu:fi22c04 antikoerper, wu:fj85e11 antikoerper, zgc:162029 antikoerper, zgc:66164 antikoerper, NMMHC antikoerper, myosin antikoerper, non-muscle antikoerper, nonmuscle antikoerper, KLG/PTK7 antikoerper, dfna17 antikoerper, epsts antikoerper, ftns antikoerper, nmhc-ii-a antikoerper, nmmhca antikoerper, myosin heavy chain 9 antikoerper, myosin, heavy polypeptide 9, non-muscle antikoerper, myosin, heavy chain 9a, non-muscle antikoerper, myosin, heavy chain 9, non-muscle antikoerper, myosin, heavy chain 9, non-muscle L homeolog antikoerper, MYH9 antikoerper, Myh9 antikoerper, myh9a antikoerper, myh9.L antikoerper

Hintergrund: MYH9 is a myosin IIA heavy chain that contains an IQ domain and a myosin head-like domain. The protein is involved in several important functions, including cytokinesis, cell motility and maintenance of cell shape. Defects in MYH9 are the cause of non-syndromic sensorineural deafness autosomal dominant type 17, Epstein syndrome, Alport syndrome with macrothrombocytopenia, Sebastian syndrome, Fechtner syndrome and macrothrombocytopenia with progressive sensorineural deafness.

Molekulargewicht: 226 kDa (MW of target protein)

Pathways: Regulation of G-Protein Coupled Receptor Protein Signaling, Integrin Complex